143 related articles for article (PubMed ID: 31190089)
1. Staging MRI of uterine malignant mixed Müllerian tumors versus endometrial carcinomas with emphasis on dynamic enhancement characteristics.
Garza A; Elsherif SB; Faria SC; Sagebiel T; Sun J; Ma J; Bhosale PR
Abdom Radiol (NY); 2020 Apr; 45(4):1141-1154. PubMed ID: 31190089
[TBL] [Abstract][Full Text] [Related]
2. MRI appearances of uterine malignant mixed müllerian tumors.
Bharwani N; Newland A; Tunariu N; Babar S; Sahdev A; Rockall AG; Reznek RH
AJR Am J Roentgenol; 2010 Nov; 195(5):1268-75. PubMed ID: 20966339
[TBL] [Abstract][Full Text] [Related]
3. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR
Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683
[TBL] [Abstract][Full Text] [Related]
4. The comparison of clinicopathological characteristics in primary malignant mixed műllerian tumour with epithelial endometrial carcinoma.
Tong SY; Lee JM; Choi YJ; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Park CY; Kim KT
Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):44-8. PubMed ID: 22188343
[TBL] [Abstract][Full Text] [Related]
5. Comparison of survival outcomes between patients with malignant mixed mullerian tumors and high-grade endometrioid, clear cell, and papillary serous endometrial cancers.
Felix AS; Stone RA; Bowser R; Chivukula M; Edwards RP; Weissfeld JL; Linkov F
Int J Gynecol Cancer; 2011 Jul; 21(5):877-84. PubMed ID: 21666484
[TBL] [Abstract][Full Text] [Related]
6. MRI findings including gadolinium-enhanced dynamic studies of malignant, mixed mesodermal tumors of the uterus: differentiation from endometrial carcinomas.
Ohguri T; Aoki T; Watanabe H; Nakamura K; Nakata H; Matsuura Y; Kashimura M
Eur Radiol; 2002 Nov; 12(11):2737-42. PubMed ID: 12386766
[TBL] [Abstract][Full Text] [Related]
7. Malignant mixed Müllerian tumors of the uterus: sonographic spectrum.
Lee EJ; Joo HJ; Ryu HS
Ultrasound Obstet Gynecol; 2012 Mar; 39(3):348-53. PubMed ID: 21919101
[TBL] [Abstract][Full Text] [Related]
8. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.
Burghaus S; Halmen S; Gass P; Mehlhorn G; Schrauder MG; Lux MP; Renner SP; Beckmann MW; Hein A; Thiel FC
Arch Gynecol Obstet; 2016 Aug; 294(2):343-51. PubMed ID: 26711836
[TBL] [Abstract][Full Text] [Related]
9. Malignant mixed müllerian tumor of the ovary: imaging findings.
Cho SB; Park CM; Park SW; Kim SH; Kim KA; Cha SH; Chung IJ; Kim YW; Yoon YK; Kim JS
Eur Radiol; 2001; 11(7):1147-50. PubMed ID: 11471602
[TBL] [Abstract][Full Text] [Related]
10. A clinical and biological comparison between malignant mixed müllerian tumors and grade 3 endometrioid endometrial carcinomas.
Bland AE; Stone R; Heuser C; Shu J; Jazaeri A; Shutter J; Atkins K; Rice L
Int J Gynecol Cancer; 2009 Feb; 19(2):261-5. PubMed ID: 19396006
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors.
Zelmanowicz A; Hildesheim A; Sherman ME; Sturgeon SR; Kurman RJ; Barrett RJ; Berman ML; Mortel R; Twiggs LB; Wilbanks GD; Brinton LA
Gynecol Oncol; 1998 Jun; 69(3):253-7. PubMed ID: 9648597
[TBL] [Abstract][Full Text] [Related]
12. Eight cases of malignant mixed Müllerian tumor (carcinosarcoma) of the uterus: findings in SurePath™ cervical cytology.
Gupta N; Dudding N; Smith JH
Diagn Cytopathol; 2014 Feb; 42(2):165-9. PubMed ID: 22865798
[TBL] [Abstract][Full Text] [Related]
13. Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus.
Clement PB; Zubovits JT; Young RH; Scully RE
Int J Gynecol Pathol; 1998 Jul; 17(3):211-22. PubMed ID: 9656116
[TBL] [Abstract][Full Text] [Related]
14. Malignant mixed müllerian tumor versus high-grade endometrial carcinoma and aggressive variants of endometrial carcinoma: a comparative analysis of survival.
George E; Lillemoe TJ; Twiggs LB; Perrone T
Int J Gynecol Pathol; 1995 Jan; 14(1):39-44. PubMed ID: 7883424
[TBL] [Abstract][Full Text] [Related]
15. Carcinosarcomas (malignant mixed Müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics.
Kernochan LE; Garcia RL
J Natl Compr Canc Netw; 2009 May; 7(5):550-6; quiz 557. PubMed ID: 19460280
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
Mikami Y; Hata S; Kiyokawa T; Manabe T
Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
[TBL] [Abstract][Full Text] [Related]
17. Malignant mixed Müllerian tumors of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 44 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Sullivan S; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):18-24. PubMed ID: 9454654
[TBL] [Abstract][Full Text] [Related]
18. Serous carcinomatous component championed by heparin-binding EGF-like growth factor (HB-EGF) predisposing to metastasis and recurrence in stage I uterine malignant mixed mullerian tumor.
Zhang L; Shimizu D; Killeen JL; Honda SA; Lu D; Stanoyevitch A; Lin F; Wang B; Monuki ES; Carbone M
Hum Pathol; 2016 Jul; 53():159-67. PubMed ID: 26980026
[TBL] [Abstract][Full Text] [Related]
19. Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience.
Hoskins PJ; Le N; Ellard S; Lee U; Martin LA; Swenerton KD; Tinker AV;
Gynecol Oncol; 2008 Jan; 108(1):58-62. PubMed ID: 17935761
[TBL] [Abstract][Full Text] [Related]
20. [Carcinosarcomas (malignant mixed Mullerian tumors) of the uterus. Morphology, pathogenetic aspects and prognostic factors].
Horn LC; Dallacker M; Bilek K
Pathologe; 2009 Jul; 30(4):292-301. PubMed ID: 19495763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
